Bromocriptine Mesylate Capsules 5 mg

Description

Bromocriptine mesylate capsules, 5 mg per capsule, supplied in bottles of 30 and held as laboratory reference material. Bromocriptine is an ergot-derived dopamine D2 agonist, approved and marketed in the United States as a generic prescription medicine, and it is not a controlled substance. Research use only, not for human consumption. Adults 21 and over, with purchase restrictions by state.

What is in the bottle

The label strength refers to bromocriptine, with the mesylate counterion adding mass on top. Salt against base is the first thing to settle on any certificate, because a figure quoted on the wrong basis is wrong by a fixed percentage every time.

You will find bromocriptine mesylate capsules under the ancillary reference materials in the anabolics reference materials catalogue.

Milligrams per bottle

5 mg per capsule times 30 capsules is 150 mg. At $92 the arithmetic gives about $0.61 per milligram, printed under the price. Capsule products carry their encapsulation cost in that figure the same way tablets carry compression, so comparing a 5 mg capsule against bulk powder by milligram alone flatters the powder.

Our note on price per milligram and the certificate walkthrough cover the two numbers we publish for every lot.

What is in bromocriptine mesylate capsules

Bromocriptine is 2-bromo-alpha-ergocryptine, an ergoline alkaloid with a tripeptide-like side chain and a bromine atom on the indole ring. It is a large, light-sensitive molecule, and the bromine is both a structural feature and a convenient analytical handle in mass spectrometry, where the isotope pattern of bromine is distinctive.

A separate bromocriptine product exists at 0.8 mg in a quick-release formulation for an unrelated indication. It is the same molecule in a different dosage form and the two are not interchangeable, which is a formulation fact worth stating because the names are nearly identical.

United States regulatory status

Bromocriptine holds current United States approval, is available generically, and appears on no federal controlled substance schedule. The ancillary shelf is consistently like this and the distinction is worth keeping sharp: an approved generic medicine and an unapproved Schedule III steroid are not the same kind of object. Approval records sit with the FDA, and labelling for marketed products is indexed at DailyMed.

Packaging notes

We ship bromocriptine mesylate capsules in the original sealed container with the lot number legible. We do not decant, relabel or combine lots, because a reference material whose lot cannot be named is no longer a reference material. The listing for bromocriptine mesylate capsules states the storage conditions and the stability window we are willing to stand behind. Nothing is supplied in unmarked packaging, and we will not omit the compound name from a label or a customs declaration.

Testing on this lot

Purity for bromocriptine mesylate capsules is measured by HPLC and published as the percentage of total peak area the expected compound accounts for. Identity is confirmed by mass spectrometry, which is a different claim: it says this molecule has the mass the structure predicts, and a pure sample of the wrong molecule would fail there rather than on purity. Residual solvent is given in parts per million. System suitability and the reference standard used are named on the report, because a purity figure without a method behind it is a number somebody typed.

The same two tests run on every lot of bromocriptine mesylate capsules that we list. How to read a certificate of analysis and check the lab before you check the numbers both apply to the document on this page.

Questions we decline

The question people actually want answered about bromocriptine mesylate capsules is what it does and how much. We do not answer it, in copy or by email, and a research-use-only sentence at the bottom of a page that answered it would be decoration.

So the listing for bromocriptine mesylate capsules stays with the things that are verifiable: content per unit, purity, identity, solvent residue, lot number, where the item can ship. Our article on research use only explains why that line is a description of a sales channel rather than a legal shield, and the FDA’s drug pages hold the agency’s position in its own words.

This is laboratory stock. Research use only for this item, not for human consumption, and not approved for administration to a person or an animal in any jurisdiction. Sales are limited to adults 21 and over and to states where the compound is lawful, which the listing states and the checkout applies. Lot certificates, current and historical, sit on the lab results page beside the note on price per milligram.